Lasofoxifene as a potential treatment for ER plus metastatic breast cancer.

被引：4
|
作者：
Laine, Muriel
Fanning, Sean William
Greene, Marianne
Chang, Ya-fang
Phung, Linda
Tan, Tina T.
Hiipakka, Richard
Komm, Barry
Greene, Geoffrey
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Sermonix, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1056
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Activity and safety of biweekly docetaxel plus capecitabine as first-line treatment for patients with metastatic breast cancer.
    Llorca, C
    Mayordomo, J
    Adrover, E
    Alvarez, I
    Madroñal, C
    Burillo, M
    Sanz, J
    Lorenzo, A
    Palombo, H
    Janariz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 73S - 73S
  • [42] Baseline genomic alterations and the activity of lasofoxifene (LAS) plus abemaciclib (Abema) in patients with ER+/HER2-metastatic breast cancer (mBC): the ELAINE 2 study
    Damodaran, Senthil
    Cristofanilli, Massimo
    Goetz, Matthew
    O'Sullivan, Ciara
    Riordan, Gary
    Rugo, Hope
    Stover, Daniel
    Wander, Seth
    Carroll, Dominic
    Plourde, Paul V.
    Portman, David J.
    Yam, Einav Nili-Gal
    CANCER RESEARCH, 2024, 84 (09)
  • [43] Targeting the NAD plus Salvage Pathway: Synergistic Therapeutic Strategy for ER plus Metastatic Breast Cancer
    Riggins, Rebecca B.
    Ranjit, Suman
    ENDOCRINOLOGY, 2023, 164 (11)
  • [44] Inflammatory markers in metastatic breast cancer.
    Sahin, Ugur
    Petekkaya, Hilbrahim
    Gecmez, Gizem
    Babacan, Taner
    Roach, Emir C.
    Sarici, Saim Furkan
    Arslan, Cagatay
    Arik, Zafer
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.
    Ge, Xuan
    Behrendt, Carolyn E.
    Yost, Susan Elaine
    Patel, Niki
    Samoa, Raynald
    Stewart, Daphne B.
    Sedrak, Mina S.
    Lavasani, Sayeh Moazami
    Waisman, James Ross
    Yuan, Yuan
    Mortimer, Joanne E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER plus Breast Cancer
    Zboril, Emily K.
    Grible, Jacqueline M.
    Boyd, David C.
    Hairr, Nicole S.
    Leftwich, Tess J.
    Esquivel, Madelyn F.
    Duong, Alex K.
    Turner, Scott A.
    Ferreira-Gonzalez, Andrea
    Olex, Amy L.
    Sartorius, Carol A.
    Dozmorov, Mikhail G.
    Harrell, J. Chuck
    CANCERS, 2023, 15 (12)
  • [47] A real-world retrospective study of apatinib plus chemotherapy in metastatic breast cancer.
    Zhu, Anjie
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Li, Qing
    Zhang, Pin
    Xu, Binghe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Patient specific treatment sequencing in ER plus advanced breast cancer
    Johnston, Stephen
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 590 - 590
  • [49] Treatment decision-making and financial toxicity in metastatic breast cancer.
    Wan, Clara
    Williams, Courtney
    Ingram, Stacey A.
    Lawhon, Valerie
    Pierce, Jennifer Young
    Dekle, Kendal
    Lowman, Janel
    Jones, Jonathan
    Azuero, Andres
    Gilbert, Aidan
    Rocque, Gabrielle Betty
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [50] A pilot phase II trial of cabergoline in the treatment of metastatic breast cancer.
    Costa, Ricardo Lima Barros
    Santa-Maria, Cesar Augusto
    Scholtens, Denise M.
    Jain, Sarika
    Gradishar, William John
    Clevenger, Charles V.
    Kaklamani, Virginia G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345